High Risk for Persistent Opioid Use in Young People With Sarcoma

Roughly one quarter of adolescents and young adults with sarcoma will continue to use opioids after their cancer treatment, a new study shows.

Related Keywords

New York ,United States ,Columbia University ,American ,William Dahut ,Melissa Beauchemin ,Columbia University School Of Nursing ,Ibm ,Young ,American Cancer Society ,Columbia University School ,New York City ,Medscape Medical ,Medscape Medical News ,Pain Management ,Sarcoma ,Malignant Soft Tissue Tumor ,Opioids ,Cancer ,Alignant Neoplasia ,Arcinoma ,Osteosarcoma ,Spain ,Malignant Primary Bone Neoplasm ,Adolescent Medicine ,Bone Sarcoma ,Nonrhabdomyosarcoma Soft Tissue Sarcoma ,Soft Tissue Sarcoma ,Young Adult ,Analgesia ,Analgesic ,Breast Cancer ,Alignant Breast Neoplasm ,